Morcellator Lawyer Georgia

  • 56 views
Uploaded on

morcellator injuries georgia

morcellator injuries georgia

More in: Law
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Be the first to comment
    Be the first to like this
No Downloads

Views

Total Views
56
On Slideshare
0
From Embeds
0
Number of Embeds
1

Actions

Shares
Downloads
0
Comments
0
Likes
0

Embeds 0

No embeds

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
    No notes for slide

Transcript

  • 1. 5/24/2014 a-georgialawyer.com http://a-georgialawyer.com/ 1/1 News, musings and commentary on dietary supplements & pharmaceutical law issues, technology, and litigation. 404-451-7781 www.a- georgialawyer.com No advice, though. Lawyers for consumers and injured people.(No advice on this blog, though) TOLL FREE 855-525- 3955 mark(at)markzamora.com A Georgia Lawyer Thursday, May 22, 2014 The FDA has discouraged the use of laparoscopic power morcellation for the removal of the uterus (hysterectomy) or uterine fibroids (myomectomy) in women because, based on an analysis of currently available data, it poses a risk of spreading unsuspected cancerous tissue, notably uterine sarcomas, beyond the uterus. Laparoscopic power morcellation is one of several available treatments for fibroids. It is a procedure that uses a medical device to divide the uterine tissue into smaller pieces or fragments so it can be removed through a small incision in the abdomen, such as during laparoscopy. Uterine fibroids are non-cancerous growths that originate from the smooth muscle tissue in the wall of the uterus. According to the National Institutes of Health, most women will develop uterine fibroids at some point in their lives. While most uterine fibroids do not cause problems, they can cause symptoms, such as heavy or prolonged menstrual bleeding, pelvic pressure or pain, and frequent urination, sometimes requiring medical or surgical therapy. Based on an analysis of currently available data, the FDA has determined that approximately 1 in 350 women who are undergoing hysterectomy or myomectomy for fibroids have an unsuspected type of uterine cancer called uterine sarcoma. If laparoscopic power morcellation is performed in these women, there is a risk that the procedure will spread the cancerous tissue within the abdomen and May News - Morcellator Warning from the FDA Name Email * Message * Send Contact Us (Just Know we can't help everyone) About Me Share 1 More Next Blog» markzamoralaw@gmail.com